Related Experiment Video
Updated: Jun 10, 2025

08:16
Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
Published on: June 17, 2015
18.1K
Olfactory bulb stimulation mitigates Alzheimer's-like disease progression
Morteza Salimi1, Milad Nazari2,3, Payam Shahsavar1
1Department of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
CNS Neuroscience & Therapeutics
|October 15, 2024
Summary
Electrical stimulation of the olfactory bulb (OB) improved working memory and reduced Alzheimer's disease (AD) pathology in rats. This minimally invasive approach offers a new therapeutic avenue for AD by modulating brain networks.
Area of Science:
- Neuroscience
- Neurology
- Biomedical Engineering
Background:
- Alzheimer's disease (AD) poses a significant challenge, with deep brain stimulation (DBS) showing potential but limited by invasiveness.
- The olfactory bulb (OB), affected early in AD and connected to memory centers, presents a promising, accessible target for intervention.
- Restoring neural activity in memory circuits is crucial for mitigating AD progression.
Purpose of the Study:
- To investigate the effects of olfactory bulb electrical stimulation on working memory in an amyloid beta (Aβ) rat model of AD.
- To assess pathological and electrophysiological changes in key brain regions, including the OB, medial prefrontal cortex, hippocampus, and entorhinal cortex.
Main Methods:
- Male Wistar rats modeling Alzheimer's-like disease received daily 1-hour bilateral OB electrical stimulation for 18 days.
- Histological, behavioral, and local field potential analyses were conducted post-stimulation.
- Electrode implantation targeted specific brain regions for stimulation and recording.
Main Results:
- Olfactory bulb stimulation effectively counteracted amyloid beta plaque accumulation.
- Working memory impairments associated with AD were prevented by OB stimulation.
- Enhanced power across frequency bands and gamma-band functional connectivity were observed in stimulated regions during memory tasks.
Conclusions:
- Olfactory pathway stimulation shows potential for modulating deep memory networks in Alzheimer's disease treatment.
- The accessibility of the olfactory pathway via the nasal cavity supports the development of minimally invasive therapeutic strategies.
- This preclinical study provides a foundation for novel, less invasive interventions for AD targeting the olfactory system.
Keywords:
Alzheimer's diseasedeep brain stimulationmemory modulationolfactory bulb stimulationolfactory pathwayMore Related Videos
Related Concept Videos
Alzheimer's Disease: Treatment
166
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
166
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449

